1. Home
  2. PHAR vs UVSP Comparison

PHAR vs UVSP Comparison

Compare PHAR & UVSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pharming Group N.V.

PHAR

Pharming Group N.V.

N/A

Current Price

$18.36

Market Cap

1.1B

Sector

Health Care

ML Signal

N/A

Logo Univest Financial Corporation

UVSP

Univest Financial Corporation

HOLD

Current Price

$36.47

Market Cap

983.8M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
PHAR
UVSP
Founded
1988
1876
Country
Netherlands
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
983.8M
IPO Year
2020
1994

Fundamental Metrics

Financial Performance
Metric
PHAR
UVSP
Price
$18.36
$36.47
Analyst Decision
Strong Buy
Hold
Analyst Count
3
2
Target Price
$38.33
$35.00
AVG Volume (30 Days)
12.9K
177.8K
Earning Date
05-07-2026
04-22-2026
Dividend Yield
N/A
2.40%
EPS Growth
N/A
21.32
EPS
N/A
3.13
Revenue
N/A
$328,056,000.00
Revenue This Year
$10.04
$11.65
Revenue Next Year
$2.51
$4.77
P/E Ratio
$3,041.22
$11.72
Revenue Growth
N/A
9.64
52 Week Low
$8.05
$26.54
52 Week High
$21.34
$37.72

Technical Indicators

Market Signals
Indicator
PHAR
UVSP
Relative Strength Index (RSI) 57.20 62.65
Support Level $16.90 $32.00
Resistance Level $17.70 $37.72
Average True Range (ATR) 0.64 0.78
MACD 0.14 0.19
Stochastic Oscillator 61.10 71.89

Price Performance

Historical Comparison
PHAR
UVSP

About PHAR Pharming Group N.V.

Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.

About UVSP Univest Financial Corporation

Univest Financial Corp is engaged in domestic banking services for individuals, businesses, municipalities and non-profit organizations. The bank has three operating segments; Banking segment provides financial services including a full range of banking services such as deposit taking, loan origination, and servicing, mortgage banking, other general banking services, and equipment lease financing, Wealth Management segment offers investment advisory, financial planning, trust and brokerage services, and The Insurance segment includes a full-service insurance brokerage agency offering commercial property and casualty insurance, employee benefits solutions, personal insurance lines and human resources consulting. It generates majority of its revenue from the banking segment.

Share on Social Networks: